These findings highlight the critical role of cytosolic mtDNA-induced cGAS-STING activation in the pathogenesis of obesity-related diabetic cardiomyopathy (DCM) and provide preclinical evidence supporting the targeting of this pathway as a potential therapeutic strategy for DCM. This evidence concerns the gene STING1 and diabetic cardiomyopathy.